
Thymosin Alpha-1 Peptide Therapy
Benefits, Side Effects, Cost & Protocols
Thymosin alpha-1 (thymalfasin) is a peptide naturally produced by the thymus gland that plays a critical role in immune system modulation. It enhances T-cell function, natural killer cell activity, and dendritic cell maturation. It is approved in several countries for hepatitis B and C treatment and as an immune adjuvant.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is Thymosin Alpha-1 Best For?
How Thymosin Alpha-1 Works
Enhances T-cell function, dendritic cell maturation, and overall immune response modulation.
Thymosin Alpha-1 FAQ
What is THYMOSIN ALPHA-1?
Thymosin Alpha-1 is a thymic peptide with established immune-modulating properties, researched for immune enhancement and as an adjunct in various health conditions.
How does THYMOSIN ALPHA-1 work?
Enhances T-cell function, dendritic cell maturation, and overall immune response modulation.
Is THYMOSIN ALPHA-1 legal to buy?
THYMOSIN ALPHA-1 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy THYMOSIN ALPHA-1?
THYMOSIN ALPHA-1 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does THYMOSIN ALPHA-1 belong to?
THYMOSIN ALPHA-1 is primarily classified as a immune support peptide. Peptides researched for immune modulation, antimicrobial activity, and immune system support.
What are the research benefits of THYMOSIN ALPHA-1?
THYMOSIN ALPHA-1 has been studied for: Immune modulation, T-cell support, Tissue repair support. Immune modulation; established research peptide.
Key Studies
858 total on PubMed0Thymosin alpha-1
Am J Health Syst PharmPhase 3
Thymosin alpha-1 shows modest efficacy for hepatitis B and improved outcomes when combined with interferon for hepatitis C
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
J Coll Physicians Surg Pak
Thymosin alpha 1 improved pulmonary function, blood oxygen, and shortened hospital stay in AECOPD patients
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis
Yang YF, Zhao W, Zhong YD et al
Antiviral Res · Antiviral Res
6 months treatment plus 6 months follow-up
Talpha1 showed delayed benefit versus IFNalpha, with superior virological response at 6-month follow-up
The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression
Soeroto AY, Suryadinata H, Yanto TA et al
Inflammopharmacology
Thymosin alpha-1 reduced COVID-19 mortality in moderate-to-critical patients versus placebo
Thymosin Alpha-1 Compound Data
Thymosin Alpha-1 News
I Reviewed Over 100 Peptide Studies—These 4 Findings Stood Out the Most - Men's Health
Men's Health · today
Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells - Nature
Nature · 7 months ago
Q&A: Should you trust trending peptide injections? - UVA Today
UVA Today · 1 month ago
RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work. - ProPublica
ProPublica · 1 month ago
Peptide Stacking Is Everywhere—But Should You Be Doing It? - Goop
Goop · 1 month ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Thymosin Alpha-1 with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Thymosin Alpha-1.
Take the Quiz →